Skip to content
Search

Latest Stories

Follow Us:
Top Stories

When Medical Misinformation Costs Lives: Balancing Free Speech and Public Health

From Ivermectin to cancer cures, false health claims spread faster than facts—testing democracy’s limits.

Opinion

When Medical Misinformation Costs Lives: Balancing Free Speech and Public Health
person wearing gold wedding band

In my corner of the world, it feels like 2020 all over again, experiencing the push and pull between losing someone I love due to medical misinformation, all while holding respect for free speech.

The tension between combating medical misinformation and protecting free speech represents one of the most challenging dilemmas of our age. On one side lies the very real danger of false health claims that can literally cost lives. On the other side, there is a fundamental democratic principle that has historically protected unpopular truths from suppression.


The stakes of walking this tightrope are undeniably high. We have witnessed how vaccine misinformation can fuel disease outbreaks, how false cancer cure claims can lead desperate patients away from effective treatments, and how pandemic conspiracy theories can undermine public health responses. And yet, freedom of speech remains crucial to our democratic republic.

While upholding one of our country’s core rights can feel theoretical, the human cost of medical misinformation isn't that abstract. It is measured in concrete, preventable deaths and suffering.

One of those deaths was my friend. Out of respect for my friend’s grieving family, I will call him “John.”

John was diagnosed with prostate cancer just over a year ago. Instead of listening to his oncologist and following their treatment plan, John chose to take Ivermectin for his cancer and ended up succumbing to its side effects.

Ivermectin, a broad-spectrum anti-parasitic agent, was approved by the U.S. Food and Drug Administration (FDA) for humans to treat certain parasitic worm infections and specific skin conditions.

In addition to the conditions mentioned above, Ivermectin is not approved, authorized, or recommended by the FDA or the Centers for Disease Control and Prevention (CDC) for the treatment or prevention of COVID-19 or other conditions, such as cancer.

John fell down the dangerous path of medical misinformation five years ago during the pandemic. Unfortunately, medical experts, as well as family and friends like me, could not pull him back to safety.

Sitting at John’s memorial, I felt the weight of grief press into something sharper. It was resentment at the leaders and public figures who, with their platforms and bully pulpit, chose to amplify falsehoods instead of truth, and anger that their words carried more influence than the quiet counsel of doctors who had dedicated their lives to healing.

It is one thing to mourn the natural course of illness; it is another to grieve a death hastened by deliberate misinformation. This is not an abstract editorial on medical care in America; it is personal, raw, and a reminder that the stakes of this debate are not theoretical. They are measured by the real loss of people like John.

Of course, John had agency, and as an adult, he had the right to seek alternative therapies and treatments as prescribed by an alternative medicine provider, within the law. But John was swayed by thought leaders and elected officials whom he trusted, and this is where the discussion of misinformation and free speech gets mired in a morass.

We should also acknowledge that “misinformation” itself can be contested. The line between settled science, emerging evidence, and genuine uncertainty isn't always clear.

History offers sobering lessons about the risks of empowering authorities to determine truth. Medical consensus has been wrong before. Doctors once promoted cigarettes, dismissed the link between handwashing and infection, and resisted germ theory itself. Breakthrough discoveries often began as heretical ideas that challenged establishment thinking.

The challenge of balancing the two intensifies in our current information ecosystem. Social media algorithms amplify engagement, and health misinformation often generates intense emotional reactions that boost its spread. A false claim can circle the globe before accurate information can put on its shoes. The traditional marketplace-of-ideas theory assumed roughly equal access to platforms and audiences. Unfortunately, those assumptions no longer hold.

So, where does this leave us? Heavy-handed censorship risks creating martyrs, driving misinformation underground where it becomes harder to counter, and eroding public trust in institutions. But a completely hands-off approach allows falsehoods to proliferate with devastating consequences.

Perhaps the answer lies not in choosing between these extremes but in pursuing a more nuanced approach. This might include: prominent placement of accurate information from credible sources without outright censorship of alternative views; transparency about content moderation decisions and clear, consistently applied standards; investment in digital literacy education that helps people evaluate health claims critically; and, perhaps most importantly, holding leaders to a higher standard when it comes to the dissemination of incorrect medical information.

Ultimately, this isn't a problem we can solve once and for all with the right policy. It requires ongoing calibration, humility about our own certainty, and recognition that both unchecked misinformation and aggressive censorship carry serious risks. We must find ways to protect public health without sacrificing the open discourse that allows science and democracy to function.

Until we can do that, there will continue to be unnecessary goodbyes, like the one I had with John.

Lynn Schmidt is a columnist and Editorial Board member with the St. Louis Post-Dispatch. She holds a master's of science in political science as well as a bachelor's of science in nursing.


Read More

Senators Criticize Trump Administration’s Demands to Access Health Data as a Condition for Lifesaving Aid
Roberto “Bear” Guerra/ProPublica. Source image: Getty Images

Senators Criticize Trump Administration’s Demands to Access Health Data as a Condition for Lifesaving Aid

What Happened: Citing reporting by ProPublica, eight Democratic U.S. senators have criticized the Trump administration’s demands to access the health data of millions of people as a condition of giving lifesaving aid to other countries. In a letter to Secretary of State Marco Rubio, the senators, including minority leader Chuck Schumer, said the U.S. demands were “unprecedented and at odds with U.S. policy concerning the data of American citizens.”

The inquiry into the administration’s approach to foreign health data referred to a ProPublica story published in June about agreements the U.S. struck with African countries — and the risks they posed to people there. Experts told ProPublica that the deals are vague and lack language used in most data-sharing agreements to adequately limit what information is collected and how it can be used. As a result, they said, there is an increased risk that individuals’ personal data could be exposed, misused or commercialized without their consent.

Keep ReadingShow less
As Temperatures Rise and Federal Funding Falls, Drowning Risks Grow
a group of kids in a pool
Photo by Kevin Paes on Unsplash

As Temperatures Rise and Federal Funding Falls, Drowning Risks Grow

July 25 marked World Drowning Day. More than 4000 people die from unintentional drowning in the United States each year. This translates into an average of 11 drowning deaths per day. Children ages one to four are at greatest risk, making drowning the leading cause of death for that group and the second leading cause of death for children ages five to 14.

Two emerging trends could make those numbers worse: federal funding cuts that have weakened drowning prevention efforts and hotter summers that are driving more people to water to cool off. Together, these trends threaten to deepen long-standing disparities that already place Black, Indigenous, autistic, and low-income communities at greater risk.

Keep ReadingShow less
FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.

The FDA’s changing drug approval policies raise concerns about political influence, scientific standards, drug safety, and the future of U.S. pharmaceutical regulation.

JHVEPhoto/Getty Images

FDA Turmoil: Political Interference Threatens Drug Safety Standards

Over the past three decades, drug development in the United States accelerated dramatically. Industry spending increased tenfold between the 1980s and 2019; the number of manufacturers grew; clinical trials became more sophisticated; and new technologies and precision medicines emerged. The Food and Drug Administration kept pace, building processes, standards, and a scientific culture that supported this rapid innovation. It offered pharmaceutical companies a predictable regulatory environment and a level playing field, producing substantial benefits for consumers and researchers alike.

In little more than a year, however, the Trump administration has upended many of these FDA norms. It has tied certain drug approvals to political considerations through a new, opaque program; imposed labeling changes without new scientific evidence; forced out experienced career scientists; replaced respected experts on advisory panels; and promoted unproven therapies. While some of these moves have drawn limited media attention, most have escaped public notice—even though they threaten national health standards and consumer safety. And legal guardrails may be too weak to prevent or limit their effects.

Keep ReadingShow less
Gynecologist doing ultrasound of pregnant woman in hospital.

Rural hospital labor and delivery closures are creating maternity care deserts—and costing communities physicians, jobs, families, and economic investment.

Maskot/Getty Images

No Doctor, No Delivery, No Future

Today, less than half of rural hospitals in the U.S. still offer labor and delivery services, and since 2020, 139 of them have stopped delivering babies altogether. That's usually treated as public health statistic. It's also an economic one. Each closure doesn't just push expectant mothers into longer drives to the hospital, it pushes out physicians, jobs, young families, and the investment that follows them. So, what happens to a town after it loses its only labor and delivery unit?

The answer, it turns out, is a lot more than a longer drive to the hospital. More than a third of U.S. counties, 35.1 percent by the most recent national count, are now what researchers call maternity care deserts: places with no hospital or birth center offering obstetric care and no obstetric clinicians at all. Since the end of 2020, 139 rural hospitals have stopped delivering babies, and today less than half of rural hospitals nationwide still offer labor and delivery services.

Keep ReadingShow less